Markhoff & Mittman, P.C. Workers’ Compensation Practice Update Announced

January 12, 2026 - PRESSADVANTAGE - Markhoff & Mittman, P.C. announced the release of an updated informational ...
Le Lézard

FDA Confirms a PDUFA Goal Date of August 30, 2026 for the sBLA Submission of Ropeginterferon Alfa-2b-njft in Essential Thrombocythemia (ET)

PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles ...